Epigenetic regulation of neutrophil development and function

Seminars in Immunology

Volumn 28, Issue 2, 2016, Pages 83-93

  Ostuni, Renato ^a   Natoli, Gioacchino ^b   Cassatella, Marco A ^c   Tamassia, Nicola ^c  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Cytokine; Epigenetic; Granulopoiesis; Neutrophil; Transcription factor

Indexed keywords

BETA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSCRIPTION FACTOR; CYTOKINE;

CELL LINEAGE; CELL MATURATION; CHROMATIN; CONGENITAL DISORDER; CYTOKINE PRODUCTION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GRANULOCYTE FUNCTION; GRANULOPOIESIS; HUMAN; INFLAMMATION; MONOCYTE; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MYELOPOIESIS; NEUTROPHILS;

EID: 84964341342     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.04.002     Document Type: Review

References (148)

1. Scapini P., Tamassia N., Pucillo C., Cassatella M.A. Granulocytes and mast cells. Fundamental Immunology 2013, 468-486. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. W.E. Paul (Ed.).
2. Thomas C.J., Schroder K. Pattern recognition receptor function in neutrophils. Trends Immunol. 2013, 34:317-328.
3. Tecchio C., Micheletti A., Cassatella M.A. Neutrophil-derived cytokines: facts beyond expression. Front. Immunol. 2014, 5:508.
4. Jaillon S., Galdiero M.R., Del Prete D., Cassatella M.A., Garlanda C., Mantovani A. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 2013, 35:377-394.
5. Tamassia N., Le Moigne V., Calzetti F., Donini M., Gasperini S., Ear T., et al. The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J. Immunol. 2007, 178:7344-7356.
6. Davidson D., Zaytseva A., Miskolci V., Castro-Alcaraz S., Vancurova I., Patel H. Gene expression profile of endotoxin-stimulated leukocytes of the term new born: control of cytokine gene expression by interleukin-10. PLoS One 2013, 8:e53641.
7. Lara-Astiaso D., Weiner A., Lorenzo-Vivas E., Zaretsky I., Jaitin D.A., David E., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 2014, 345:943-949.
8. Lyons P.A., Koukoulaki M., Hatton A., Doggett K., Woffendin H.B., Chaudhry A.N., et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 2007, 8:64.
9. Tang Y., Xu H., Du X., Lit L., Walker W., Lu A., et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab. 2006, 26:1089-1102.
10. Doulatov S., Notta F., Laurenti E., Dick J.E. Hematopoiesis: a human perspective. Cell Stem Cell 2012, 10:120-136.
11. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
12. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010, 33:657-670.
13. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
14. Varol C., Mildner A., Jung S. Macrophages: development and tissue specialization. Annu. Rev. Immunol. 2015, 33:643-675.
15. Lavin Y., Mortha A., Rahman A., Merad M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 2015, 15:731-744.
16. Gomez Perdiguero E., Klapproth K., Schulz C., Busch K., Azzoni E., Crozet L., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015, 518:547-551.
17. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
18. Casanova-Acebes M., Pitaval C., Weiss L.A., Nombela-Arrieta C., Chevre R., González-A N., et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 2013, 153:1025-1035.
19. Zhang D., Chen G., Manwani D., Mortha A., Xu C., Faith J.J., et al. Neutrophil ageing is regulated by the microbiome. Nature 2015, 525:528-532.
20. Manz M.G., Boettcher S. Emergency granulopoiesis. Nat. Rev. Immunol. 2014, 14:302-314.
21. Zhao J.L., Ma C., O'Connell R.M., Mehta A., DiLoreto R., Heath J.R., et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell 2014, 14:445-459.
22. Boettcher S., Gerosa R.C., Radpour R., Bauer J., Ampenberger F., Heikenwalder M., et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 2014, 124:1393-1403.
23. Kwak H.J., Liu P., Bajrami B., Xu Y., Park S.Y., Nombela-Arrieta C., et al. Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. Immunity 2015, 42:159-171.
24. Glass C.K., Natoli G. Molecular control of activation and priming in macrophages. Nat. Immunol. 2015, 17:26-33.
25. Heinz S., Romanoski C.E., Benner C., Glass C.K. The selection and function of cell type-specific enhancers. Nat. Rev. Mol. Cell Biol. 2015, 16:144-154.
26. Iwafuchi-Doi M., Zaret K.S. Pioneer transcription factors in cell reprogramming. Genes Dev. 2014, 28:2679-2692.
27. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577.
28. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000, 288:1439-1441.
29. Barozzi I., Simonatto M., Bonifacio S., Yang L., Rohs R., Ghisletti S., et al. Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol. Cell 2014, 54:844-857.
30. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
31. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
32. Gosselin D., Link V.M., Romanoski C.E., Fonseca G.J., Eichenfield D.Z., Spann N.J., et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014, 159:1327-1340.
33. Soucie E.L., Weng Z., Geirsdottir L., Molawi K., Maurizio J., Fenouil R., et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells. Science 2016, 351:aad5510.
34. Chen L., Kostadima M., Martens J.H., Canu G., Garcia S.P., Turro E., et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science 2014, 345:1251033.
35. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
36. Ostuni R., Natoli G. Lineages, cell types and functional states: a genomic view. Curr. Opin. Cell Biol. 2013, 25:759-764.
37. Spitz F., Furlong E.E. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
38. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828.
39. Anderson M.K., Weiss A.H., Hernandez-Hoyos G., Dionne C.J., Rothenberg E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 2002, 16:285-296.
40. Spooner C.J., Cheng J.X., Pujadas E., Laslo P., Singh H. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 2009, 31:576-586.
41. Carotta S., Dakic A., D'Amico A., Pang S.H., Greig K.T., Nutt S.L., et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 2010, 32:628-641.
42. Kueh H.Y., Champhekar A., Nutt S.L., Elowitz M.B., Rothenberg E.V. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science 2013, 341:670-673.
43. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126:755-766.
44. Dahl R., Walsh J.C., Lancki D., Laslo P., Iyer S.R., Singh H., et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat. Immunol. 2003, 4:1029-1036.
45. Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., Okuno Y., et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 2004, 36:624-630.
46. Scott L.M., Civin C.I., Rorth P., Friedman A.D. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992, 80:1725-1735.
47. Iwasaki H., Mizuno S., Arinobu Y., Ozawa H., Mori Y., Shigematsu H., et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 2006, 20:3010-3021.
48. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004, 21:853-863.
49. Heath V., Suh H.C., Holman M., Renn K., Gooya J.M., Parkin S., et al. C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 2004, 104:1639-1647.
50. Ma O., Hong S., Guo H., Ghiaur G., Friedman A.D. Granulopoiesis requires increased C/EBPalpha compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells. PLoS One 2014, 9:e95784.
51. Chen H., Ray-Gallet D., Zhang P., Hetherington C.J., Gonzalez D.A., Zhang D.E., et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 1995, 11:1549-1560.
52. Okuno Y., Huang G., Rosenbauer F., Evans E.K., Radomska H.S., Iwasaki H., et al. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol. Cell Biol. 2005, 25:2832-2845.
53. Yeamans C., Wang D., Paz-Priel I., Torbett B.E., Tenen D.G., Friedman A.D. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 2007, 110:3136-3142.
54. Cooper S., Guo H., Friedman A.D. The +37 kb cebpa enhancer is critical for cebpa myeloid gene expression and contains functional sites that bind SCL, GATA2, C/EBPalpha, PU.1, and additional ets factors. PLoS One 2015, 10:e0126385.
55. Schutte J., Wang H., Antoniou S., Jarratt A., Wilson N.K., Riepsaame J., et al. An experimentally validated network of nine haematopoietic transcription factors reveals mechanisms of cell state stability. eLife 2016, 5.
56. van Oevelen C., Collombet S., Vicent G., Hoogenkamp M., Lepoivre C., Badeaux A., et al. C/EBPalpha activates pre-existing and de novo macrophage enhancers during induced pre-B cell transdifferentiation and myelopoiesis. Stem Cell Rep. 2015, 5:232-247.
57. Di Stefano B., Sardina J.L., van Oevelen C., Collombet S., Kallin E.M., Vicent G.P., et al. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature 2014, 506:235-239.
58. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008, 26:535-584.
59. Kurotaki D., Yamamoto M., Nishiyama A., Uno K., Ban T., Ichino M., et al. IRF8 inhibits C/EBPalpha activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils. Nat. Commun. 2014, 5:4978.
60. Tamura T., Nagamura-Inoue T., Shmeltzer Z., Kuwata T., Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 2000, 13:155-165.
61. Tsujimura H., Nagamura-Inoue T., Tamura T., Ozato K. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J. Immunol. 2002, 169:1261-1269.
62. Mancino A., Termanini A., Barozzi I., Ghisletti S., Ostuni R., Prosperini E., et al. A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages. Genes Dev. 2015, 29:394-408.
63. Kurotaki D., Osato N., Nishiyama A., Yamamoto M., Ban T., Sato H., et al. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 2013, 121:1839-1849.
64. Yamamoto M., Kato T., Hotta C., Nishiyama A., Kurotaki D., Yoshinari M., et al. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One 2011, 6:e25812.
65. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996, 87:307-317.
66. Hambleton S., Salem S., Bustamante J., Bigley V., Boisson-Dupuis S., Azevedo J., et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 2011, 365:127-138.
67. Salem S., Langlais D., Lefebvre F., Bourque G., Bigley V., Haniffa M., et al. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation. Blood 2014, 124:1894-1904.
68. Gombart A.F., Shiohara M., Kwok S.H., Agematsu K., Komiyama A., Koeffler H.P. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon. Blood 2001, 97:2561-2567.
69. Paul F., Arkin Y., Giladi A., Jaitin D.A., Kenigsberg E., Keren-Shaul H., et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 2015, 163:1663-1677.
70. van der Meer L.T., Jansen J.H., van der Reijden B.A. Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia 2010, 24:1834-1843.
71. Duan Z., Zarebski A., Montoya-Durango D., Grimes H.L., Horwitz M. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol. Cell Biol. 2005, 25:10338-10351.
72. Saleque S., Kim J., Rooke H.M., Orkin S.H. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 2007, 27:562-572.
73. McGhee L., Bryan J., Elliott L., Grimes H.L., Kazanjian A., Davis J.N., et al. Gfi-1 attaches to the nuclear matrix associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J. Cell Biochem. 2003, 89:1005-1018.
74. Person R.E., Li F.Q., Duan Z., Benson K.F., Wechsler J., Papadaki H.A., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 2003, 34:308-312.
75. Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu. Rev. Immunol. 2011, 29:399-413.
76. Bartels M., Murphy K., Rieter E., Bruin M. Understanding chronic neutropenia: life is short. Br. J. Haematol. 2016, 172:157-169.
77. Skokowa J., Cario G., Uenalan M., Schambach A., Germeshausen M., Battmer K., et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat. Med. 2006, 12:1191-1197.
78. Notta F., Zandi S., Takayama N., Dobson S., Gan O.I., Wilson G., et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 2016, 351:aab2116.
79. Perie L., Duffy K.R., Kok L., de Boer R.J., Schumacher T.N. The branching point in erythro-myeloid differentiation. Cell 2015, 163:1655-1662.
80. Mercier F.E., Scadden D.T. Not all created equal: lineage hard-wiring in the production of blood. Cell 2015, 163:1568-1570.
81. Davey M.S., Tamassia N., Rossato M., Bazzoni F., Calzetti F., Bruderek K., et al. Failure to detect production of IL-10 by activated human neutrophils. Nat. Immunol. 2011, 12:1017-1018.
82. Davidson D., Patel H., Degoy A.C., Gershkovich I., Vancurova I., Miskolci V. Differential effect of exogenous interleukin-10 versus glucocorticoids on gene expression and pro-inflammatory cytokine release by polymorphonuclear leukocytes and monocytes of the newly born. Am. J. Transl. Res. 2013, 5:103-115.
83. Cassatella M.A. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 1999, 73:369-509.
84. Scapini P., Calzetti F., Cassatella M.A. On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J. Immunol. Methods 1999, 232:121-129.
85. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014, 14:36-49.
86. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
87. Brubaker S.W., Bonham K.S., Zanoni I., Kagan J.C. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 2015, 33:257-290.
88. Panne D., Maniatis T., Harrison S.C. An atomic model of the interferon-beta enhanceosome. Cell 2007, 129:1111-1123.
89. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
90. Tamassia N., Calzetti F., Ear T., Cloutier A., Gasperini S., Bazzoni F., et al. Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-gamma in human neutrophils. Eur. J. Immunol. 2007, 37:2627-2634.
91. van Bruggen R., Drewniak A., Tool A.T., Jansen M., van Houdt M., Geissler J., et al. Toll-like receptor responses in IRAK-4-deficient neutrophils. J. Innate Immun. 2010, 2:280-287.
92. McDonald P.P., Bovolenta C., Cassatella M.A. Activation of distinct transcription factors in neutrophils by bacterial LPS, interferon-gamma, and GM-CSF and the necessity to overcome the action of endogenous proteases. Biochemistry 1998, 37:13165-13173.
93. Zimmermann M., Aguilera F.B., Castellucci M., Rossato M., Costa S., Lunardi C., et al. Chromatin remodelling and autocrine TNFalpha are required for optimal interleukin-6 expression in activated human neutrophils. Nat. Commun. 2015, 6:6061.
94. Cervantes J.L., Dunham-Ems S.M., La Vake C.J., Petzke M.M., Sahay B., Sellati T.J., et al. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3683-3688.
95. Bergstrom B., Aune M.H., Awuh J.A., Kojen J.F., Blix K.J., Ryan L., et al. TLR8 Senses staphylococcus aureus RNA in human primary monocytes and macrophages and induces IFN-beta production via a TAK1-IKKbeta-IRF5 signaling pathway. J. Immunol. 2015, 195:1100-1111.
96. Tamassia N., Le Moigne V., Rossato M., Donini M., McCartney S., Calzetti F., et al. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J. Immunol. 2008, 181:6563-6573.
97. Cassatella M.A., Mosna F., Micheletti A., Lisi V., Tamassia N., Cont C., et al. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells 2011, 29:1001-1011.
98. Tamassia N., Bazzoni F., Le Moigne V., Calzetti F., Masala C., Grisendi G., et al. IFN-beta Expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling. J. Immunol. 2012, 189:1500-1509.
99. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
100. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8459-8464.
101. Tamassia N., Cassatella M.A. Cytoplasmic receptors recognizing nucleic acids and mediating immune functions in neutrophils. Curr. Opin. Pharmacol. 2013, 13:547-554.
102. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
103. Kaikkonen M.U., Spann N.J., Heinz S., Romanoski C.E., Allison K.A., Stender J.D., et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 2013, 51:310-325.
104. Iyer S.S., Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 2012, 32:23-63.
105. Acorci-Valerio M.J., Bordon-Graciani A.P., Dias-Melicio L.A., de Assis Golim M., Nakaira-Takahagi E., de Campos Soares A.M. Role of TLR2 and TLR4 in human neutrophil functions against Paracoccidioides brasiliensis. Scand. J. Immunol. 2010, 71:99-108.
106. Alvarez-Arellano L., Camorlinga-Ponce M., Maldonado-Bernal C., Torres J. Activation of human neutrophils with Helicobacter pylori and the role of Toll-like receptors 2 and 4 in the response. FEMS Immunol. Med. Microbiol. 2007, 51:473-479.
107. Glowacka E., Lewkowicz P., Rotsztejn H., Zalewska A. IL-8 IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. Adv. Med. Sci. 2010, 55:254-260.
108. Lewkowicz N., Klink M., Mycko M.P., Lewkowicz P. Neutrophil-CD4 + CD25 + T regulatory cell interactions: a possible new mechanism of infectious tolerance. Immunobiology 2013, 218:455-464.
109. De Santo C., Arscott R., Booth S., Karydis I., Jones M., Asher R., et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 2010, 11:1039-1046.
110. Reglier H., Arce-Vicioso M., Fay M., Gougerot-Pocidalo M.A., Chollet-Martin S. Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine 1998, 10:192-198.
111. Leoratti F.M., Trevelin S.C., Cunha F.Q., Rocha B.C., Costa P.A., Gravina H.D., et al. Neutrophil paralysis in Plasmodium vivax malaria. PLoS Negl. Trop. Dis. 2012, 6:e1710.
112. Smedman C., Gardlund B., Nihlmark K., Gille-Johnson P., Andersson J., Paulie S. ELISpot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8 MIP-1beta and TNF-alpha. J. Immunol. Methods 2009, 346:1-8.
113. Morel C., Badell E., Abadie V., Robledo M., Setterblad N., Gluckman J.C., et al. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice. Eur. J. Immunol. 2008, 38:437-447.
114. McColl S.R., St-Onge M., Dussault A.A., Laflamme C., Bouchard L., Boulanger J., et al. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 2006, 20:187-189.
115. Zhang X., Majlessi L., Deriaud E., Leclerc C., Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009, 31:761-771.
116. Tamassia N., Zimmermann M., Castellucci M., Ostuni R., Bruderek K., Schilling B., et al. Cutting edge: an inactive chromatin configuration at the IL-10 locus in human neutrophils. J. Immunol. 2013, 190:1921-1925.
117. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
118. Lewkowicz N., Mycko M.P., Przygodzka P., Cwiklinska H., Cichalewska M., Matysiak M., et al. Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10. Mucosal Immunol. 2016, 9:364-378.
119. Pelletier M., Micheletti A., Cassatella M.A. Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells. J. Leukoc. Biol. 2010, 88:1163-1170.
120. Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 2015, 16:448-457.
121. Guo Y., Xu F., Lu T., Duan Z., Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat. Rev. 2012, 38:904-910.
122. Tanaka T., Narazaki M., Ogata A., Kishimoto T. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin. Immunol. 2014, 26:88-96.
123. Cicco N.A., Lindemann A., Content J., Vandenbussche P., Lubbert M., Gauss J., et al. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 1990, 75:2049-2052.
124. Tamassia N., Cassatella M.A., Bazzoni F. Fast and accurate quantitative analysis of cytokine gene expression in human neutrophils. Methods Mol. Biol. 2014, 1124:451-467.
125. Wang P., Wu P., Anthes J.C., Siegel M.I., Egan R.W., Billah M.M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994, 83:2678-2683.
126. Takeichi O., Saito I., Tsurumachi T., Saito T., Moro I. Human polymorphonuclear leukocytes derived from chronically inflamed tissue express inflammatory cytokines in vivo. Cell. Immunol. 1994, 156:296-309.
127. Aarden L.A., De Groot E.R., Schaap O.L., Lansdorp P.M. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 1987, 17:1411-1416.
128. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
129. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004, 430:218-222.
130. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991, 174:1209-1220.
131. Rossato M., Curtale G., Tamassia N., Castellucci M., Mori L., Gasperini S., et al. IL-10-induced microRNA-187 negatively regulates TNF-alpha IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3101-3110.
132. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol. Ther. 2008, 117:244-279.
133. Zimmermann M., Arruda-Silva F., Bianchetto-Aguilera F., Finotti G., Calzetti F., Scapini P., et al. IFNalpha enhances the production of IL-6 by human neutrophils activated via TLR8. Sci. Rep. 2016, 6:19674.
134. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022.
135. Wiench M., John S., Baek S., Johnson T.A., Sung M.H., Escobar T., et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J. 2011, 30:3028-3039.
136. Ronnerblad M., Andersson R., Olofsson T., Douagi I., Karimi M., Lehmann S., et al. Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation. Blood 2014, 123:e79-89.
137. Zilbauer M., Rayner T.F., Clark C., Coffey A.J., Joyce C.J., Palta P., et al. Genome-wide methylation analyses of primary human leukocyte subsets identifies functionally important cell-type-specific hypomethylated regions. Blood 2013, 122:e52-60.
138. Reinius L.E., Acevedo N., Joerink M., Pershagen G., Dahlen S.E., Greco D., et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012, 7:e41361.
139. Coit P., Yalavarthi S., Ognenovski M., Zhao W., Hasni S., Wren J.D., et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J. Autoimmun. 2015, 58:59-66.
140. Ciavatta D.J., Yang J., Preston G.A., Badhwar A.K., Xiao H., Hewins P., et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J. Clin. Invest. 2010, 120:3209-3219.
141. Saeed S., Quintin J., Kerstens H.H., Rao N.A., Aghajanirefah A., Matarese F., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014, 345:1251086.
142. Joshi A., Pooley C., Freeman T.C., Lennartsson A., Babina M., Schmidl C., et al. Transcription factor promoter, and enhancer utilization in human myeloid cells. J. Leukoc. Biol. 2015, 97:985-995.
143. Schmidl C., Renner K., Peter K., Eder R., Lassmann T., Balwierz P.J., et al. Transcription and enhancer profiling in human monocyte subsets. Blood 2014, 123:e90-99.
144. Novershtern N., Subramanian A., Lawton L.N., Mak R.H., Haining W.N., McConkey M.E., et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 2011, 144:296-309.
145. Gonzalez A.J., Setty M., Leslie C.S. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation. Nat. Genet. 2015, 47:1249-1259.
146. Gantier M.P. The not-so-neutral role of microRNAs in neutrophil biology. J. Leukoc. Biol. 2013, 94:575-583.
147. Carpenter S., Aiello D., Atianand M.K., Ricci E.P., Gandhi P., Hall L.L., et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013, 341:789-792.
148. Elling R., Chan J., Fitzgerald K.A. Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression. Eur. J. Immunol. 2016, 46:504-512.